These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 10158409)

  • 21. Europe needs a single, deep capital market.
    Hodgson J
    Nat Biotechnol; 2002 Oct; 20(10):960-1. PubMed ID: 12355101
    [No Abstract]   [Full Text] [Related]  

  • 22. Beyond the clinic: redefining hospital ambulatory care.
    Rogut L
    Pap Ser United Hosp Fund N Y; 1997 Jul; ():1-62. PubMed ID: 10351749
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Access to tangible research materials in biomedical research: conditions of access and their effect on research.
    Monotti AL
    J Law Med; 2006 Aug; 14(1):86-101. PubMed ID: 16937783
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 10 ways to create shareholder value.
    Rappaport A
    Harv Bus Rev; 2006 Sep; 84(9):66-77, 155. PubMed ID: 16967621
    [TBL] [Abstract][Full Text] [Related]  

  • 25. US research firms put under pressure to sell.
    Reich ES
    Nature; 2013 Jul; 499(7457):137-8. PubMed ID: 23846640
    [No Abstract]   [Full Text] [Related]  

  • 26. International Monetary Fund and World Bank policies can hurt poor, study says.
    Drajem M
    Int J Health Serv; 2001; 31(2):439-40. PubMed ID: 11407176
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Objective risk adjustment improves calculated ROI for capital projects.
    Holmes RL; Schroeder RE; Harrington LF
    Healthc Financ Manage; 2000 Dec; 54(12):48-52. PubMed ID: 11141687
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Physician entrepreneur: lessons learned in raising capital for biomedical innovation.
    Soleimani F; Kharabi DG
    Curr Opin Anaesthesiol; 2010 Apr; 23(2):209-17. PubMed ID: 20173634
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Securitization of a Drug Development Mega-Fund: The Time-Certain Research-Backed Obligation.
    Ortiz CE; Stone CA; Zissu A
    Pharmaceut Med; 2020 Jun; 34(3):167-173. PubMed ID: 32266695
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Technology governance strategies for maximizing healthcare economic value. Developing management systems for IT.
    Langabeer J; Delgado R; Mikhail O
    J Healthc Inf Manag; 2007; 21(4):19-24. PubMed ID: 19195277
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The value of information technology in healthcare.
    Skinner RI
    Front Health Serv Manage; 2003; 19(3):3-15. PubMed ID: 12645778
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Financing growth through REITs (real estate investment trusts).
    Press SH; Sherwin JS
    Rev Fed Am Health Syst; 1989; 22(1):57-8, 63. PubMed ID: 10291962
    [No Abstract]   [Full Text] [Related]  

  • 33. Companies struggle amid stock market gloom.
    Mitchell P
    Nat Biotechnol; 2002 Oct; 20(10):961-2. PubMed ID: 12355102
    [No Abstract]   [Full Text] [Related]  

  • 34. How venture capital works.
    Zider B
    Harv Bus Rev; 1998; 76(6):131-9. PubMed ID: 10187243
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biotech finance: a family affair.
    Hurwitz EM
    Nat Biotechnol; 1999 Feb; 17 Suppl():BE35-7. PubMed ID: 10052326
    [No Abstract]   [Full Text] [Related]  

  • 36. Investment banking firms are forming rescue teams for distressed hospitals.
    Palm KS
    Mod Healthc; 1988 Sep; 18(38):41. PubMed ID: 10289040
    [No Abstract]   [Full Text] [Related]  

  • 37. No more money. NCFE stops payments; hospitals sink further into red. National Century Financial Enterprises.
    Taylor M
    Mod Healthc; 2002 Nov; 32(45):12. PubMed ID: 12462886
    [No Abstract]   [Full Text] [Related]  

  • 38. Shades of AHERF. Debate since collapse of Enron revisits many issues raised in Pittsburgh healthcare system's high-profile bankruptcy.
    Jaklevic MC
    Mod Healthc; 2002 Feb; 32(5):34-5. PubMed ID: 11859820
    [No Abstract]   [Full Text] [Related]  

  • 39. Financing growth through cash-flow and asset-value credit facilities.
    Anderson DM
    Healthc Financ Manage; 1998 Nov; 52(11):74-5. PubMed ID: 10187636
    [No Abstract]   [Full Text] [Related]  

  • 40. Credit squeeze won't let up. Cheaper deals elusive for healthcare borrowers.
    Evans M
    Mod Healthc; 2009 Jan; 39(3):8-9. PubMed ID: 19213104
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.